- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Positron and GE extend buyout deadline
Positron and GE Medical Systems have extended the deadline forPositron to complete its acquisition of GE's PET assets (SCAN7/31/96). The deadline, originally set for the end of last year,has been extended until March 31. Positron, of Houston, TX, saidthe
Positron and GE Medical Systems have extended the deadline forPositron to complete its acquisition of GE's PET assets (SCAN7/31/96). The deadline, originally set for the end of last year,has been extended until March 31. Positron, of Houston, TX, saidthe extension enables it to complete regulatory requirements andto finalize its financing package.
In other Positron news, the company last month announced two PETsystem orders: one to a mobile imaging company that will set upa mobile PET route in the Cleveland area, and another to a customerin the New York City area. Positron now has four PET scanner ordersin its backlog.
Also last month, Positron entered a sales and marketing agreementwith Beijing Aerospace Chang Feng Medical Devices, which willsell Positron PET systems in China. Chang Feng is the largestsupplier of CT and MRI scanners in China, according to Positron.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
